日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diabetes and obesity reduce FIB-4 accuracy in MASLD referral pathways

糖尿病和肥胖会降低MASLD转诊途径中FIB-4的准确性

Shaheen, Abdel-Aziz; Baguley, Elizabeth; Swain, Mark G; Tam, Matthew; Ma, Mang Ming; Sebastiani, Giada; Jiang, Jason; Lee, Frank; Medellin, Alexandra; Abraldes, Juan G

Thalamic homeostatic transcriptomic signatures are altered in a mouse model of cholestatic liver injury and are mitigated by systemic TNF neutralization

在胆汁淤积性肝损伤的小鼠模型中,丘脑稳态转录组特征发生改变,而全身性TNF中和可减轻这种改变。

Almishri, Wagdi; Dunn, Jeff F; Swain, Mark G

Evaluating the clinical care, quality of life and overall experiences of patients with primary biliary cholangitis (PBC) during the pandemic: A Canadian mixed-methods study

评估新冠疫情期间原发性胆汁性胆管炎(PBC)患者的临床护理、生活质量和总体体验:一项加拿大混合方法研究

Baguley, Elizabeth; Knaub, Madelyn; VanDyke, Jessica; Hirschfield, Gideon; Swain, Mark G; Wright, Gail; McCaughey, Deirdre; Shaheen, Abdel Aziz

A review of multidisciplinary care in metabolic dysfunction-associated steatohepatitis and cardiometabolic disease, with a focus on Canada

对代谢功能障碍相关脂肪性肝炎和心血管代谢疾病的多学科诊疗进行综述,重点关注加拿大。

Kim, James; Raggi, Paolo; Carreau, Anne-Marie; Wharton, Sean; Cheng, Alice Y Y; Swain, Mark G

Prominent Eustachian Valve Mimicking a Transjugular Intrahepatic Portosystemic Shunt-Associated Thrombosis

突出的咽鼓管瓣膜模拟经颈静脉肝内门体分流术相关血栓形成

Malik, Getanshu; Herget, Eric; Nguyen, Henry H; Swain, Mark G

Projected Healthcare System Cost Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in Canada

加拿大代谢功能障碍相关脂肪肝疾病预计给医疗保健系统带来的成本负担

Memedovich, K Ally; Shaheen, Abdel Aziz; Swain, Mark G; Clement, Fiona M

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

Seladelpar治疗原发性胆汁性胆管炎患者3个月的疗效和安全性:ENHANCE,一项3期随机、安慰剂对照研究

Hirschfield, Gideon M; Shiffman, Mitchell L; Gulamhusein, Aliya; Kowdley, Kris V; Vierling, John M; Levy, Cynthia; Kremer, Andreas E; Zigmond, Ehud; Andreone, Pietro; Gordon, Stuart C; Bowlus, Christopher L; Lawitz, Eric J; Aspinall, Richard J; Pratt, Daniel S; Raikhelson, Karina; Gonzalez-Huezo, Maria S; Heneghan, Michael A; Jeong, Sook-Hyang; Ladrón de Guevara, Alma L; Mayo, Marlyn J; Dalekos, George N; Drenth, Joost P H; Janczewska, Ewa; Leggett, Barbara A; Nevens, Frederik; Vargas, Victor; Zuckerman, Eli; Corpechot, Christophe; Fassio, Eduardo; Hinrichsen, Holger; Invernizzi, Pietro; Trivedi, Palak J; Forman, Lisa; Jones, David E J; Ryder, Stephen D; Swain, Mark G; Steinberg, Alexandra; Boudes, Pol F; Choi, Yun-Jung; McWherter, Charles A

A qualitative patient interview study to understand the experience of patients with nonalcoholic steatohepatitis

一项旨在了解非酒精性脂肪性肝炎患者经历的定性患者访谈研究

Swain, Mark G; Pettersson, Billie; Meyers, Oren; Venerus, Meredith; Oscarsson, Jan

Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial

塞他那昔布对原发性胆汁性胆管炎患者生活质量结局的影响:一项 II 期随机对照试验

Jones, David; Carbone, Marco; Invernizzi, Pietro; Little, Nicola; Nevens, Frederik; Swain, Mark G; Wiesel, Philippe; Levy, Cynthia

Impact of depression and antidepressant use on clinical outcomes of hepatitis B and C: a population-based study

抑郁症和抗抑郁药使用对乙型和丙型肝炎临床结局的影响:一项基于人群的研究

Shaheen, Abdel Aziz; Kaplan, Gilaad G; Sharkey, Keith A; Lethebe, B Cord; Swain, Mark G